🔒
Price chart and 15 days of daily prices
Candlestick chart with moving averages, Bollinger bands and MACD.
Register free to view.
Security Profile
- Security Type
- Common Stock
- CUSIP
- 21217B100
Business: Contineum Therapeutics, Inc. is a clinical stage biopharmaceutical company focused on discovering and developing novel, oral small molecule therapies for neuroscience, inflammation and immunology (NI&I) indications with high unmet need.
Company Contact
- CEO
- Carmine Stengone
- CFO
- Peter Slover
- Headquarters
- 10578 Science Center Drive, Suite 200, San Diego, CA 92121
- Phone
- 858-333-5280
- Investor Relations
- Peter Slover · pslover@contineum-tx.com